HRT Financial’s Pulse Biosciences PLSE Stock Holding History

HRT Financial’s Portfolio PLSE Stock Details PLSE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-11,734	Closed	-$188K	–	3340
2025 Q1	$188K	Buy	+11,734	New	+$219K	﹤0.01%	2048

Other funds holding PLSE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GAM

Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

WIM

Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return

HRT Financial's PLSE Position: Q2 2025 in Review

HRT Financial sold out of Pulse Biosciences (PLSE) in Q2 2025, closing a stake of 11,734 shares — an estimated $188K sold.

HRT Financial first reported a position in PLSE in Q1 2025 and held it in 1 quarter. The position peaked at $188K in Q1 2025. 86 funds tracked by Wall St. Rank hold PLSE as of Q2 2025.

HRT Financial reported no remaining Pulse Biosciences position as of Q2 2025 after selling out during the quarter.
HRT Financial sold 11,734 Pulse Biosciences shares in Q2 2025, an estimated $188K.
HRT Financial first reported a position in Pulse Biosciences in Q1 2025 and held it in 1 quarter.
HRT Financial's Pulse Biosciences position peaked at $188K in Q1 2025.
86 funds tracked by Wall St. Rank held Pulse Biosciences as of Q2 2025.

Based on HRT Financial's 13F filing for Q2 2025, filed 14 Aug 2025.